The Experts below are selected from a list of 117 Experts worldwide ranked by ideXlab platform
Ruben J Azocar - One of the best experts on this subject based on the ideXlab platform.
-
Correction to: The effect of Tegaderm™ versus EyeGard® on Eyelid Erythema during general anesthesia: a randomized-controlled trial
Canadian Journal of Anesthesia Journal canadien d'anesthésie, 2020Co-Authors: Dan M Drzymalski, Katelyn Ward, Josephine M Hernandez, Joyce Hoot, Shiuchung Au, Feishiuann Clarissa Yang, Ruben J AzocarAbstract:In the article entitled: “The effect of Tegaderm™ versus EyeGard® on Eyelid Erythema during general anesthesia: a randomized-controlled trial” published online and in the May 2020 print issue of the Journal, Can J Anesth 2020; DOI: 10.1007/s12630-020-01588-6, the trial registration date in the abstract should read 25 May, 2018 (instead of 8 June, 2018).
-
the effect of tegaderm versus eyegard on Eyelid Erythema during general anesthesia a randomized controlled trial
Canadian Journal of Anaesthesia-journal Canadien D Anesthesie, 2020Co-Authors: Dan M Drzymalski, Katelyn Ward, Josephine M Hernandez, Joyce Hoot, Shiuchung Au, Feishiuann Clarissa Yang, Ruben J AzocarAbstract:PURPOSE: Application of adhesive tape to the Eyelids during general anesthesia decreases the risk of corneal abrasion but may increase the risk of Eyelid injury. The aim of this study was to determine if there is a difference in Eyelid Erythema when covering the Eyelid with either Tegaderm or an EyeGard(R). METHODS: We conducted a prospective, randomized, double-blind, split-face study of patients undergoing general anesthesia at an urban tertiary care academic medical centre. Each patient was randomized to having one Eyelid covered with Tegaderm and the other with EyeGard. Photographs were taken prior to extubation and evaluated by three dermatologists. The primary outcome was the incidence of postoperative Eyelid Erythema. Secondary outcomes included the incidence of corneal abrasion and patient satisfaction. RESULTS: A total of 151 patients were included in our final analysis. Erythema was present on 117 (77%) Eyelids covered with Tegaderm and 105 (70%) Eyelids covered with EyeGard (% difference, 8; 95% confidence interval, 2 to 14; P = 0.03). No corneal abrasions were reported. The median [interquartile range] patient satisfaction score with Eyelid condition was similar with Tegaderm vs EyeGard (5 [5-5] vs 5 [5-5], respectively; P = 0.84). CONCLUSION: We found a small increase in postoperative Eyelid Erythema when using Tegaderm compared with EyeGard. While EyeGard could decrease the risk of Eyelid Erythema, this should be balanced against other potential benefits of Tegaderm such as protection from fluids leaking onto the cornea. TRIAL REGISTRATION: www.ClinicalTrials.gov (NCT03549429); registered 8 June, 2018.
-
The effect of Tegaderm™ versus EyeGard® on Eyelid Erythema during general anesthesia: a randomized-controlled trial
Canadian Journal of Anesthesia Journal canadien d'anesthésie, 2020Co-Authors: Dan M Drzymalski, Katelyn Ward, Josephine M Hernandez, Joyce Hoot, Shiuchung Au, Feishiuann Clarissa Yang, Ruben J AzocarAbstract:Purpose Application of adhesive tape to the Eyelids during general anesthesia decreases the risk of corneal abrasion but may increase the risk of Eyelid injury. The aim of this study was to determine if there is a difference in Eyelid Erythema when covering the Eyelid with either Tegaderm™ or an EyeGard®. Methods We conducted a prospective, randomized, double-blind, split-face study of patients undergoing general anesthesia at an urban tertiary care academic medical centre. Each patient was randomized to having one Eyelid covered with Tegaderm and the other with EyeGard. Photographs were taken prior to extubation and evaluated by three dermatologists. The primary outcome was the incidence of postoperative Eyelid Erythema. Secondary outcomes included the incidence of corneal abrasion and patient satisfaction. Results A total of 151 patients were included in our final analysis. Erythema was present on 117 (77%) Eyelids covered with Tegaderm and 105 (70%) Eyelids covered with EyeGard (% difference, 8; 95% confidence interval, 2 to 14; P = 0.03). No corneal abrasions were reported. The median [interquartile range] patient satisfaction score with Eyelid condition was similar with Tegaderm vs EyeGard (5 [5–5] vs 5 [5–5], respectively; P = 0.84). Conclusion We found a small increase in postoperative Eyelid Erythema when using Tegaderm compared with EyeGard. While EyeGard could decrease the risk of Eyelid Erythema, this should be balanced against other potential benefits of Tegaderm such as protection from fluids leaking onto the cornea. Trial registration www.ClinicalTrials.gov (NCT03549429); registered 8 June, 2018. Objectif L’application de ruban adhésif sur les paupières pendant l’anesthésie générale réduit le risque d’abrasion cornéenne mais pourrait augmenter le risque de lésion aux paupières. L’objectif de cette étude était de déterminer s’il existe une différence dans l’incidence d’érythème de la paupière lorsque l’on couvre la paupière à l’aide d’un Tegaderm™ ou d’un EyeGard®. Méthode Nous avons réalisé une étude prospective, randomisée, à double insu et à visage divisé auprès de patients subissant une anesthésie générale dans un centre médical universitaire urbain de soins tertiaires. Chaque patient a été randomisé à avoir une paupière couverte de Tegaderm et l’autre d’un EyeGard. Des photos ont été prises avant l’extubation et évaluées par trois dermatologistes. Le critère d’évaluation principal était l’incidence d’érythème postopératoire de la paupière. Les critères secondaires comprenaient l’incidence d’abrasion cornéenne et la satisfaction des patients. Résultats Au total, 151 patients ont été inclus dans notre analyse finale. Il y avait présence d’érythème sur 117 (77 %) paupières couvertes de Tegaderm et 105 (70 %) paupières couvertes d’un EyeGard (% de différence, 8; intervalle de confiance 95 %, 2 à 14; P = 0,03). Aucune abrasion cornéenne n’a été rapportée. Le score médian [écart interquartile] de satisfaction des patients en ce qui touchait à l’état de leurs paupières était semblable pour le Tegaderm et le EyeGard (5 [5–5] vs 5 [5–5], respectivement; P = 0,84). Conclusion Nous avons observé une légère augmentation du nombre d’érythèmes postopératoires de la paupière lors de l’utilisation du Tegaderm comparativement au EyeGard. Alors que le EyeGard pourrait réduire le risque d’érythème de la paupière, il convient de sous-peser ses avantages par rapport aux autres avantages potentiels du Tegaderm tels que la protection contre les liquides coulant sur la cornée. Enregistrement de l’étude www.ClinicalTrials.gov (NCT03549429); enregistrée le 8 juin 2018.
Dan M Drzymalski - One of the best experts on this subject based on the ideXlab platform.
-
Correction to: The effect of Tegaderm™ versus EyeGard® on Eyelid Erythema during general anesthesia: a randomized-controlled trial
Canadian Journal of Anesthesia Journal canadien d'anesthésie, 2020Co-Authors: Dan M Drzymalski, Katelyn Ward, Josephine M Hernandez, Joyce Hoot, Shiuchung Au, Feishiuann Clarissa Yang, Ruben J AzocarAbstract:In the article entitled: “The effect of Tegaderm™ versus EyeGard® on Eyelid Erythema during general anesthesia: a randomized-controlled trial” published online and in the May 2020 print issue of the Journal, Can J Anesth 2020; DOI: 10.1007/s12630-020-01588-6, the trial registration date in the abstract should read 25 May, 2018 (instead of 8 June, 2018).
-
the effect of tegaderm versus eyegard on Eyelid Erythema during general anesthesia a randomized controlled trial
Canadian Journal of Anaesthesia-journal Canadien D Anesthesie, 2020Co-Authors: Dan M Drzymalski, Katelyn Ward, Josephine M Hernandez, Joyce Hoot, Shiuchung Au, Feishiuann Clarissa Yang, Ruben J AzocarAbstract:PURPOSE: Application of adhesive tape to the Eyelids during general anesthesia decreases the risk of corneal abrasion but may increase the risk of Eyelid injury. The aim of this study was to determine if there is a difference in Eyelid Erythema when covering the Eyelid with either Tegaderm or an EyeGard(R). METHODS: We conducted a prospective, randomized, double-blind, split-face study of patients undergoing general anesthesia at an urban tertiary care academic medical centre. Each patient was randomized to having one Eyelid covered with Tegaderm and the other with EyeGard. Photographs were taken prior to extubation and evaluated by three dermatologists. The primary outcome was the incidence of postoperative Eyelid Erythema. Secondary outcomes included the incidence of corneal abrasion and patient satisfaction. RESULTS: A total of 151 patients were included in our final analysis. Erythema was present on 117 (77%) Eyelids covered with Tegaderm and 105 (70%) Eyelids covered with EyeGard (% difference, 8; 95% confidence interval, 2 to 14; P = 0.03). No corneal abrasions were reported. The median [interquartile range] patient satisfaction score with Eyelid condition was similar with Tegaderm vs EyeGard (5 [5-5] vs 5 [5-5], respectively; P = 0.84). CONCLUSION: We found a small increase in postoperative Eyelid Erythema when using Tegaderm compared with EyeGard. While EyeGard could decrease the risk of Eyelid Erythema, this should be balanced against other potential benefits of Tegaderm such as protection from fluids leaking onto the cornea. TRIAL REGISTRATION: www.ClinicalTrials.gov (NCT03549429); registered 8 June, 2018.
-
The effect of Tegaderm™ versus EyeGard® on Eyelid Erythema during general anesthesia: a randomized-controlled trial
Canadian Journal of Anesthesia Journal canadien d'anesthésie, 2020Co-Authors: Dan M Drzymalski, Katelyn Ward, Josephine M Hernandez, Joyce Hoot, Shiuchung Au, Feishiuann Clarissa Yang, Ruben J AzocarAbstract:Purpose Application of adhesive tape to the Eyelids during general anesthesia decreases the risk of corneal abrasion but may increase the risk of Eyelid injury. The aim of this study was to determine if there is a difference in Eyelid Erythema when covering the Eyelid with either Tegaderm™ or an EyeGard®. Methods We conducted a prospective, randomized, double-blind, split-face study of patients undergoing general anesthesia at an urban tertiary care academic medical centre. Each patient was randomized to having one Eyelid covered with Tegaderm and the other with EyeGard. Photographs were taken prior to extubation and evaluated by three dermatologists. The primary outcome was the incidence of postoperative Eyelid Erythema. Secondary outcomes included the incidence of corneal abrasion and patient satisfaction. Results A total of 151 patients were included in our final analysis. Erythema was present on 117 (77%) Eyelids covered with Tegaderm and 105 (70%) Eyelids covered with EyeGard (% difference, 8; 95% confidence interval, 2 to 14; P = 0.03). No corneal abrasions were reported. The median [interquartile range] patient satisfaction score with Eyelid condition was similar with Tegaderm vs EyeGard (5 [5–5] vs 5 [5–5], respectively; P = 0.84). Conclusion We found a small increase in postoperative Eyelid Erythema when using Tegaderm compared with EyeGard. While EyeGard could decrease the risk of Eyelid Erythema, this should be balanced against other potential benefits of Tegaderm such as protection from fluids leaking onto the cornea. Trial registration www.ClinicalTrials.gov (NCT03549429); registered 8 June, 2018. Objectif L’application de ruban adhésif sur les paupières pendant l’anesthésie générale réduit le risque d’abrasion cornéenne mais pourrait augmenter le risque de lésion aux paupières. L’objectif de cette étude était de déterminer s’il existe une différence dans l’incidence d’érythème de la paupière lorsque l’on couvre la paupière à l’aide d’un Tegaderm™ ou d’un EyeGard®. Méthode Nous avons réalisé une étude prospective, randomisée, à double insu et à visage divisé auprès de patients subissant une anesthésie générale dans un centre médical universitaire urbain de soins tertiaires. Chaque patient a été randomisé à avoir une paupière couverte de Tegaderm et l’autre d’un EyeGard. Des photos ont été prises avant l’extubation et évaluées par trois dermatologistes. Le critère d’évaluation principal était l’incidence d’érythème postopératoire de la paupière. Les critères secondaires comprenaient l’incidence d’abrasion cornéenne et la satisfaction des patients. Résultats Au total, 151 patients ont été inclus dans notre analyse finale. Il y avait présence d’érythème sur 117 (77 %) paupières couvertes de Tegaderm et 105 (70 %) paupières couvertes d’un EyeGard (% de différence, 8; intervalle de confiance 95 %, 2 à 14; P = 0,03). Aucune abrasion cornéenne n’a été rapportée. Le score médian [écart interquartile] de satisfaction des patients en ce qui touchait à l’état de leurs paupières était semblable pour le Tegaderm et le EyeGard (5 [5–5] vs 5 [5–5], respectivement; P = 0,84). Conclusion Nous avons observé une légère augmentation du nombre d’érythèmes postopératoires de la paupière lors de l’utilisation du Tegaderm comparativement au EyeGard. Alors que le EyeGard pourrait réduire le risque d’érythème de la paupière, il convient de sous-peser ses avantages par rapport aux autres avantages potentiels du Tegaderm tels que la protection contre les liquides coulant sur la cornée. Enregistrement de l’étude www.ClinicalTrials.gov (NCT03549429); enregistrée le 8 juin 2018.
Katelyn Ward - One of the best experts on this subject based on the ideXlab platform.
-
Correction to: The effect of Tegaderm™ versus EyeGard® on Eyelid Erythema during general anesthesia: a randomized-controlled trial
Canadian Journal of Anesthesia Journal canadien d'anesthésie, 2020Co-Authors: Dan M Drzymalski, Katelyn Ward, Josephine M Hernandez, Joyce Hoot, Shiuchung Au, Feishiuann Clarissa Yang, Ruben J AzocarAbstract:In the article entitled: “The effect of Tegaderm™ versus EyeGard® on Eyelid Erythema during general anesthesia: a randomized-controlled trial” published online and in the May 2020 print issue of the Journal, Can J Anesth 2020; DOI: 10.1007/s12630-020-01588-6, the trial registration date in the abstract should read 25 May, 2018 (instead of 8 June, 2018).
-
the effect of tegaderm versus eyegard on Eyelid Erythema during general anesthesia a randomized controlled trial
Canadian Journal of Anaesthesia-journal Canadien D Anesthesie, 2020Co-Authors: Dan M Drzymalski, Katelyn Ward, Josephine M Hernandez, Joyce Hoot, Shiuchung Au, Feishiuann Clarissa Yang, Ruben J AzocarAbstract:PURPOSE: Application of adhesive tape to the Eyelids during general anesthesia decreases the risk of corneal abrasion but may increase the risk of Eyelid injury. The aim of this study was to determine if there is a difference in Eyelid Erythema when covering the Eyelid with either Tegaderm or an EyeGard(R). METHODS: We conducted a prospective, randomized, double-blind, split-face study of patients undergoing general anesthesia at an urban tertiary care academic medical centre. Each patient was randomized to having one Eyelid covered with Tegaderm and the other with EyeGard. Photographs were taken prior to extubation and evaluated by three dermatologists. The primary outcome was the incidence of postoperative Eyelid Erythema. Secondary outcomes included the incidence of corneal abrasion and patient satisfaction. RESULTS: A total of 151 patients were included in our final analysis. Erythema was present on 117 (77%) Eyelids covered with Tegaderm and 105 (70%) Eyelids covered with EyeGard (% difference, 8; 95% confidence interval, 2 to 14; P = 0.03). No corneal abrasions were reported. The median [interquartile range] patient satisfaction score with Eyelid condition was similar with Tegaderm vs EyeGard (5 [5-5] vs 5 [5-5], respectively; P = 0.84). CONCLUSION: We found a small increase in postoperative Eyelid Erythema when using Tegaderm compared with EyeGard. While EyeGard could decrease the risk of Eyelid Erythema, this should be balanced against other potential benefits of Tegaderm such as protection from fluids leaking onto the cornea. TRIAL REGISTRATION: www.ClinicalTrials.gov (NCT03549429); registered 8 June, 2018.
-
The effect of Tegaderm™ versus EyeGard® on Eyelid Erythema during general anesthesia: a randomized-controlled trial
Canadian Journal of Anesthesia Journal canadien d'anesthésie, 2020Co-Authors: Dan M Drzymalski, Katelyn Ward, Josephine M Hernandez, Joyce Hoot, Shiuchung Au, Feishiuann Clarissa Yang, Ruben J AzocarAbstract:Purpose Application of adhesive tape to the Eyelids during general anesthesia decreases the risk of corneal abrasion but may increase the risk of Eyelid injury. The aim of this study was to determine if there is a difference in Eyelid Erythema when covering the Eyelid with either Tegaderm™ or an EyeGard®. Methods We conducted a prospective, randomized, double-blind, split-face study of patients undergoing general anesthesia at an urban tertiary care academic medical centre. Each patient was randomized to having one Eyelid covered with Tegaderm and the other with EyeGard. Photographs were taken prior to extubation and evaluated by three dermatologists. The primary outcome was the incidence of postoperative Eyelid Erythema. Secondary outcomes included the incidence of corneal abrasion and patient satisfaction. Results A total of 151 patients were included in our final analysis. Erythema was present on 117 (77%) Eyelids covered with Tegaderm and 105 (70%) Eyelids covered with EyeGard (% difference, 8; 95% confidence interval, 2 to 14; P = 0.03). No corneal abrasions were reported. The median [interquartile range] patient satisfaction score with Eyelid condition was similar with Tegaderm vs EyeGard (5 [5–5] vs 5 [5–5], respectively; P = 0.84). Conclusion We found a small increase in postoperative Eyelid Erythema when using Tegaderm compared with EyeGard. While EyeGard could decrease the risk of Eyelid Erythema, this should be balanced against other potential benefits of Tegaderm such as protection from fluids leaking onto the cornea. Trial registration www.ClinicalTrials.gov (NCT03549429); registered 8 June, 2018. Objectif L’application de ruban adhésif sur les paupières pendant l’anesthésie générale réduit le risque d’abrasion cornéenne mais pourrait augmenter le risque de lésion aux paupières. L’objectif de cette étude était de déterminer s’il existe une différence dans l’incidence d’érythème de la paupière lorsque l’on couvre la paupière à l’aide d’un Tegaderm™ ou d’un EyeGard®. Méthode Nous avons réalisé une étude prospective, randomisée, à double insu et à visage divisé auprès de patients subissant une anesthésie générale dans un centre médical universitaire urbain de soins tertiaires. Chaque patient a été randomisé à avoir une paupière couverte de Tegaderm et l’autre d’un EyeGard. Des photos ont été prises avant l’extubation et évaluées par trois dermatologistes. Le critère d’évaluation principal était l’incidence d’érythème postopératoire de la paupière. Les critères secondaires comprenaient l’incidence d’abrasion cornéenne et la satisfaction des patients. Résultats Au total, 151 patients ont été inclus dans notre analyse finale. Il y avait présence d’érythème sur 117 (77 %) paupières couvertes de Tegaderm et 105 (70 %) paupières couvertes d’un EyeGard (% de différence, 8; intervalle de confiance 95 %, 2 à 14; P = 0,03). Aucune abrasion cornéenne n’a été rapportée. Le score médian [écart interquartile] de satisfaction des patients en ce qui touchait à l’état de leurs paupières était semblable pour le Tegaderm et le EyeGard (5 [5–5] vs 5 [5–5], respectivement; P = 0,84). Conclusion Nous avons observé une légère augmentation du nombre d’érythèmes postopératoires de la paupière lors de l’utilisation du Tegaderm comparativement au EyeGard. Alors que le EyeGard pourrait réduire le risque d’érythème de la paupière, il convient de sous-peser ses avantages par rapport aux autres avantages potentiels du Tegaderm tels que la protection contre les liquides coulant sur la cornée. Enregistrement de l’étude www.ClinicalTrials.gov (NCT03549429); enregistrée le 8 juin 2018.
Josephine M Hernandez - One of the best experts on this subject based on the ideXlab platform.
-
Correction to: The effect of Tegaderm™ versus EyeGard® on Eyelid Erythema during general anesthesia: a randomized-controlled trial
Canadian Journal of Anesthesia Journal canadien d'anesthésie, 2020Co-Authors: Dan M Drzymalski, Katelyn Ward, Josephine M Hernandez, Joyce Hoot, Shiuchung Au, Feishiuann Clarissa Yang, Ruben J AzocarAbstract:In the article entitled: “The effect of Tegaderm™ versus EyeGard® on Eyelid Erythema during general anesthesia: a randomized-controlled trial” published online and in the May 2020 print issue of the Journal, Can J Anesth 2020; DOI: 10.1007/s12630-020-01588-6, the trial registration date in the abstract should read 25 May, 2018 (instead of 8 June, 2018).
-
the effect of tegaderm versus eyegard on Eyelid Erythema during general anesthesia a randomized controlled trial
Canadian Journal of Anaesthesia-journal Canadien D Anesthesie, 2020Co-Authors: Dan M Drzymalski, Katelyn Ward, Josephine M Hernandez, Joyce Hoot, Shiuchung Au, Feishiuann Clarissa Yang, Ruben J AzocarAbstract:PURPOSE: Application of adhesive tape to the Eyelids during general anesthesia decreases the risk of corneal abrasion but may increase the risk of Eyelid injury. The aim of this study was to determine if there is a difference in Eyelid Erythema when covering the Eyelid with either Tegaderm or an EyeGard(R). METHODS: We conducted a prospective, randomized, double-blind, split-face study of patients undergoing general anesthesia at an urban tertiary care academic medical centre. Each patient was randomized to having one Eyelid covered with Tegaderm and the other with EyeGard. Photographs were taken prior to extubation and evaluated by three dermatologists. The primary outcome was the incidence of postoperative Eyelid Erythema. Secondary outcomes included the incidence of corneal abrasion and patient satisfaction. RESULTS: A total of 151 patients were included in our final analysis. Erythema was present on 117 (77%) Eyelids covered with Tegaderm and 105 (70%) Eyelids covered with EyeGard (% difference, 8; 95% confidence interval, 2 to 14; P = 0.03). No corneal abrasions were reported. The median [interquartile range] patient satisfaction score with Eyelid condition was similar with Tegaderm vs EyeGard (5 [5-5] vs 5 [5-5], respectively; P = 0.84). CONCLUSION: We found a small increase in postoperative Eyelid Erythema when using Tegaderm compared with EyeGard. While EyeGard could decrease the risk of Eyelid Erythema, this should be balanced against other potential benefits of Tegaderm such as protection from fluids leaking onto the cornea. TRIAL REGISTRATION: www.ClinicalTrials.gov (NCT03549429); registered 8 June, 2018.
-
The effect of Tegaderm™ versus EyeGard® on Eyelid Erythema during general anesthesia: a randomized-controlled trial
Canadian Journal of Anesthesia Journal canadien d'anesthésie, 2020Co-Authors: Dan M Drzymalski, Katelyn Ward, Josephine M Hernandez, Joyce Hoot, Shiuchung Au, Feishiuann Clarissa Yang, Ruben J AzocarAbstract:Purpose Application of adhesive tape to the Eyelids during general anesthesia decreases the risk of corneal abrasion but may increase the risk of Eyelid injury. The aim of this study was to determine if there is a difference in Eyelid Erythema when covering the Eyelid with either Tegaderm™ or an EyeGard®. Methods We conducted a prospective, randomized, double-blind, split-face study of patients undergoing general anesthesia at an urban tertiary care academic medical centre. Each patient was randomized to having one Eyelid covered with Tegaderm and the other with EyeGard. Photographs were taken prior to extubation and evaluated by three dermatologists. The primary outcome was the incidence of postoperative Eyelid Erythema. Secondary outcomes included the incidence of corneal abrasion and patient satisfaction. Results A total of 151 patients were included in our final analysis. Erythema was present on 117 (77%) Eyelids covered with Tegaderm and 105 (70%) Eyelids covered with EyeGard (% difference, 8; 95% confidence interval, 2 to 14; P = 0.03). No corneal abrasions were reported. The median [interquartile range] patient satisfaction score with Eyelid condition was similar with Tegaderm vs EyeGard (5 [5–5] vs 5 [5–5], respectively; P = 0.84). Conclusion We found a small increase in postoperative Eyelid Erythema when using Tegaderm compared with EyeGard. While EyeGard could decrease the risk of Eyelid Erythema, this should be balanced against other potential benefits of Tegaderm such as protection from fluids leaking onto the cornea. Trial registration www.ClinicalTrials.gov (NCT03549429); registered 8 June, 2018. Objectif L’application de ruban adhésif sur les paupières pendant l’anesthésie générale réduit le risque d’abrasion cornéenne mais pourrait augmenter le risque de lésion aux paupières. L’objectif de cette étude était de déterminer s’il existe une différence dans l’incidence d’érythème de la paupière lorsque l’on couvre la paupière à l’aide d’un Tegaderm™ ou d’un EyeGard®. Méthode Nous avons réalisé une étude prospective, randomisée, à double insu et à visage divisé auprès de patients subissant une anesthésie générale dans un centre médical universitaire urbain de soins tertiaires. Chaque patient a été randomisé à avoir une paupière couverte de Tegaderm et l’autre d’un EyeGard. Des photos ont été prises avant l’extubation et évaluées par trois dermatologistes. Le critère d’évaluation principal était l’incidence d’érythème postopératoire de la paupière. Les critères secondaires comprenaient l’incidence d’abrasion cornéenne et la satisfaction des patients. Résultats Au total, 151 patients ont été inclus dans notre analyse finale. Il y avait présence d’érythème sur 117 (77 %) paupières couvertes de Tegaderm et 105 (70 %) paupières couvertes d’un EyeGard (% de différence, 8; intervalle de confiance 95 %, 2 à 14; P = 0,03). Aucune abrasion cornéenne n’a été rapportée. Le score médian [écart interquartile] de satisfaction des patients en ce qui touchait à l’état de leurs paupières était semblable pour le Tegaderm et le EyeGard (5 [5–5] vs 5 [5–5], respectivement; P = 0,84). Conclusion Nous avons observé une légère augmentation du nombre d’érythèmes postopératoires de la paupière lors de l’utilisation du Tegaderm comparativement au EyeGard. Alors que le EyeGard pourrait réduire le risque d’érythème de la paupière, il convient de sous-peser ses avantages par rapport aux autres avantages potentiels du Tegaderm tels que la protection contre les liquides coulant sur la cornée. Enregistrement de l’étude www.ClinicalTrials.gov (NCT03549429); enregistrée le 8 juin 2018.
Joyce Hoot - One of the best experts on this subject based on the ideXlab platform.
-
Correction to: The effect of Tegaderm™ versus EyeGard® on Eyelid Erythema during general anesthesia: a randomized-controlled trial
Canadian Journal of Anesthesia Journal canadien d'anesthésie, 2020Co-Authors: Dan M Drzymalski, Katelyn Ward, Josephine M Hernandez, Joyce Hoot, Shiuchung Au, Feishiuann Clarissa Yang, Ruben J AzocarAbstract:In the article entitled: “The effect of Tegaderm™ versus EyeGard® on Eyelid Erythema during general anesthesia: a randomized-controlled trial” published online and in the May 2020 print issue of the Journal, Can J Anesth 2020; DOI: 10.1007/s12630-020-01588-6, the trial registration date in the abstract should read 25 May, 2018 (instead of 8 June, 2018).
-
the effect of tegaderm versus eyegard on Eyelid Erythema during general anesthesia a randomized controlled trial
Canadian Journal of Anaesthesia-journal Canadien D Anesthesie, 2020Co-Authors: Dan M Drzymalski, Katelyn Ward, Josephine M Hernandez, Joyce Hoot, Shiuchung Au, Feishiuann Clarissa Yang, Ruben J AzocarAbstract:PURPOSE: Application of adhesive tape to the Eyelids during general anesthesia decreases the risk of corneal abrasion but may increase the risk of Eyelid injury. The aim of this study was to determine if there is a difference in Eyelid Erythema when covering the Eyelid with either Tegaderm or an EyeGard(R). METHODS: We conducted a prospective, randomized, double-blind, split-face study of patients undergoing general anesthesia at an urban tertiary care academic medical centre. Each patient was randomized to having one Eyelid covered with Tegaderm and the other with EyeGard. Photographs were taken prior to extubation and evaluated by three dermatologists. The primary outcome was the incidence of postoperative Eyelid Erythema. Secondary outcomes included the incidence of corneal abrasion and patient satisfaction. RESULTS: A total of 151 patients were included in our final analysis. Erythema was present on 117 (77%) Eyelids covered with Tegaderm and 105 (70%) Eyelids covered with EyeGard (% difference, 8; 95% confidence interval, 2 to 14; P = 0.03). No corneal abrasions were reported. The median [interquartile range] patient satisfaction score with Eyelid condition was similar with Tegaderm vs EyeGard (5 [5-5] vs 5 [5-5], respectively; P = 0.84). CONCLUSION: We found a small increase in postoperative Eyelid Erythema when using Tegaderm compared with EyeGard. While EyeGard could decrease the risk of Eyelid Erythema, this should be balanced against other potential benefits of Tegaderm such as protection from fluids leaking onto the cornea. TRIAL REGISTRATION: www.ClinicalTrials.gov (NCT03549429); registered 8 June, 2018.
-
The effect of Tegaderm™ versus EyeGard® on Eyelid Erythema during general anesthesia: a randomized-controlled trial
Canadian Journal of Anesthesia Journal canadien d'anesthésie, 2020Co-Authors: Dan M Drzymalski, Katelyn Ward, Josephine M Hernandez, Joyce Hoot, Shiuchung Au, Feishiuann Clarissa Yang, Ruben J AzocarAbstract:Purpose Application of adhesive tape to the Eyelids during general anesthesia decreases the risk of corneal abrasion but may increase the risk of Eyelid injury. The aim of this study was to determine if there is a difference in Eyelid Erythema when covering the Eyelid with either Tegaderm™ or an EyeGard®. Methods We conducted a prospective, randomized, double-blind, split-face study of patients undergoing general anesthesia at an urban tertiary care academic medical centre. Each patient was randomized to having one Eyelid covered with Tegaderm and the other with EyeGard. Photographs were taken prior to extubation and evaluated by three dermatologists. The primary outcome was the incidence of postoperative Eyelid Erythema. Secondary outcomes included the incidence of corneal abrasion and patient satisfaction. Results A total of 151 patients were included in our final analysis. Erythema was present on 117 (77%) Eyelids covered with Tegaderm and 105 (70%) Eyelids covered with EyeGard (% difference, 8; 95% confidence interval, 2 to 14; P = 0.03). No corneal abrasions were reported. The median [interquartile range] patient satisfaction score with Eyelid condition was similar with Tegaderm vs EyeGard (5 [5–5] vs 5 [5–5], respectively; P = 0.84). Conclusion We found a small increase in postoperative Eyelid Erythema when using Tegaderm compared with EyeGard. While EyeGard could decrease the risk of Eyelid Erythema, this should be balanced against other potential benefits of Tegaderm such as protection from fluids leaking onto the cornea. Trial registration www.ClinicalTrials.gov (NCT03549429); registered 8 June, 2018. Objectif L’application de ruban adhésif sur les paupières pendant l’anesthésie générale réduit le risque d’abrasion cornéenne mais pourrait augmenter le risque de lésion aux paupières. L’objectif de cette étude était de déterminer s’il existe une différence dans l’incidence d’érythème de la paupière lorsque l’on couvre la paupière à l’aide d’un Tegaderm™ ou d’un EyeGard®. Méthode Nous avons réalisé une étude prospective, randomisée, à double insu et à visage divisé auprès de patients subissant une anesthésie générale dans un centre médical universitaire urbain de soins tertiaires. Chaque patient a été randomisé à avoir une paupière couverte de Tegaderm et l’autre d’un EyeGard. Des photos ont été prises avant l’extubation et évaluées par trois dermatologistes. Le critère d’évaluation principal était l’incidence d’érythème postopératoire de la paupière. Les critères secondaires comprenaient l’incidence d’abrasion cornéenne et la satisfaction des patients. Résultats Au total, 151 patients ont été inclus dans notre analyse finale. Il y avait présence d’érythème sur 117 (77 %) paupières couvertes de Tegaderm et 105 (70 %) paupières couvertes d’un EyeGard (% de différence, 8; intervalle de confiance 95 %, 2 à 14; P = 0,03). Aucune abrasion cornéenne n’a été rapportée. Le score médian [écart interquartile] de satisfaction des patients en ce qui touchait à l’état de leurs paupières était semblable pour le Tegaderm et le EyeGard (5 [5–5] vs 5 [5–5], respectivement; P = 0,84). Conclusion Nous avons observé une légère augmentation du nombre d’érythèmes postopératoires de la paupière lors de l’utilisation du Tegaderm comparativement au EyeGard. Alors que le EyeGard pourrait réduire le risque d’érythème de la paupière, il convient de sous-peser ses avantages par rapport aux autres avantages potentiels du Tegaderm tels que la protection contre les liquides coulant sur la cornée. Enregistrement de l’étude www.ClinicalTrials.gov (NCT03549429); enregistrée le 8 juin 2018.
